Analytical Research Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan.
European Analytical Research Laboratories, Astellas Pharma Europe B.V., Leiden 2333 BE, the Netherlands.
J Pharm Sci. 2022 Jan;111(1):214-224. doi: 10.1016/j.xphs.2021.11.016. Epub 2021 Nov 25.
The aim of this study was to develop an in vitro drug permeability methodology which mimics the gastrointestinal environment more accurately than conventional 2D methodologies through a three-dimensional (3D) Caco-2 tubules using a microphysiological system. Such a system offers significant advantages, including accelerated cellular polarization and more accurate mimicry of the in vivo environment. This methodology was confirmed by measuring the permeability of propranolol as a model compound, and subsequently applied to those of solifenacin and bile acids for a comprehensive understanding of permeability for the drug product in the human gastrointestinal tract. To protect the Caco-2 tubules from bile acid toxicity, a mucus layer was applied on the surface of Caco-2 tubules and it enables to use simulated intestinal fluid. The assessment using propranolol reproduced results equivalent to those obtained from conventional methodology, while that using solifenacin indicated fluctuations in the permeability of solifenacin due to various factors, including interaction with bile acids. We therefore suggest that this model will serve as an alternative testing system for measuring drug absorption in an environment closely resembling that of the human gastrointestinal tract.
本研究旨在开发一种体外药物渗透方法学,通过使用微生理系统的三维(3D)Caco-2 管,比传统的 2D 方法更准确地模拟胃肠道环境。该系统具有显著的优势,包括加速细胞极化和更准确地模拟体内环境。通过测量心得安作为模型化合物的渗透性来验证该方法学,随后将其应用于索利那新和胆汁酸的渗透性,以全面了解药物在人体胃肠道中的渗透性。为了防止 Caco-2 管受到胆汁酸毒性的影响,在 Caco-2 管的表面施加了一层黏液层,从而可以使用模拟肠液。使用心得安进行评估得到的结果与传统方法学获得的结果相当,而使用索利那新进行评估则表明由于各种因素,包括与胆汁酸的相互作用,索利那新的渗透性存在波动。因此,我们建议该模型将作为一种替代测试系统,用于测量在更接近人体胃肠道环境的条件下药物的吸收。